VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be ...

Absci Corporation VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company ...

Absci Co. (NASDAQ:ABSI – Free Report) – HC Wainwright reduced their Q1 2025 earnings per share (EPS) estimates for Absci in a report released on Wednesday, March 19th. HC Wainwright analyst S.

Fireside chat on Tuesday, April 8 at 3:45 p.m. Eastern Time / 12:45 p.m. Pacific Time Interested parties may access live and archived webcasts of the fireside chat sessions on the company's investor ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating ...

Investing.com — 周一，KeyBanc Capital Markets在Absci Corp. (NASDAQ:ABSI)最近发布第四季度业务更新后，重申了其"增持"评级和5.00美元的目标价。目前，该股交易价格为3.01美元，年初至今上涨了14.89%，尽管InvestingPro数据显示分析师目标价在5美元至13美元之间存在显著波动。

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

After hours: March 24 at 7:58:16 p.m. EDT Loading Chart for ABSI ...

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Hold rating on Leap Therapeutics (LPTX – Research Report) today. The company’s ...